The "Guidelines for the diagnosis and treatment of neurally mediated syncope in children and adolescents (revised 2024)" were published in the World Journal of Pediatrics in 2024. You can access the full-text English version through the following link: https://pmc.ncbi.nlm.nih.gov/articles/PMC11502568/.
This guideline is an update of the 2018 Chinese Pediatric Cardiology Society guideline for the diagnosis and treatment of syncope in children and adolescents. It is based on the latest global research progress and provides evidence-based recommendations in the following aspects:
-
Etiological classification of syncope
-
Diagnostic procedures, including detailed history-taking, physical examination, and basic examinations such as electrocardiogram (ECG)
-
Postural tests, such as the active standing test, head-up tilt test (HUTT), and active sitting test
-
Clinical diagnosis criteria for neurally mediated syncope (NMS), including vasovagal syncope (VVS), postural orthostatic tachycardia syndrome (POTS), orthostatic hypotension (OH), orthostatic hypertension (OHT), sitting tachycardia syndrome (STS), and sitting hypertension (SHT)
-
Individualized treatment strategies, including non-pharmacological therapies such as lifestyle modifications and pharmacological therapies such as midodrine and metoprolol
-
Follow-up process and efficacy evaluation methods